Investor Dossier
Anaxago
active
Typeinvestor
Location—
Portfolio (4 investments)
PEP-THERAPY
Series A · Jul 2021
LEAD
€1.6M
Xenothera
Series C · Jun 2021
LEAD
€17.8M
Posos
Series A · Oct 2022
€10.0M
Check & Visit
Series A · May 2023
€12.4M
Investor Dossier
Series A · Jul 2021
€1.6M
Series C · Jun 2021
€17.8M
Series A · Oct 2022
€10.0M
Series A · May 2023
€12.4M